SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraemar Shipping Regulatory News (BMS)

Share Price Information for Braemar Shipping (BMS)

Share Price is delayed by 15 minutes
Get Live Data
242.00    7.00 (2.98%)
Bid:
234.00
Ask:
242.00
Spread: 8.00 (3.419%)
Market Cap: £77.41m
BMS Live PriceLast checked at - London Stock Exchange

Intraday Braemar Shipping Share Chart

Pre-Close Trading Update

3 Mar 2020 07:00

RNS Number : 7711E
Braemar Shipping Services PLC
03 March 2020
 

 

 

 

3 March 2020

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN ARTICLE 7 OF THE MARKET ABUSE REGULATION NO. 596/2014 ("MAR"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN 

 

 

BRAEMAR SHIPPING SERVICES PLC

("Braemar", the "Company" or the "Group")

Pre-Close Trading Update

 

Braemar Shipping Services plc (LSE: BMS), a leading international provider of shipbroking, financial advisory, logistics and engineering services principally to the shipping and energy industries, is pleased to provide a trading update for the year ended 29 February 2020.

 

Financial Year Ended 29 February 2020

· The Group's trading results for the second half of the year are anticipated to be approximately in line with market expectations*.

· Shipbroking had a strong second half, largely driven by strong tanker markets in the last calendar quarter of 2019 and is estimated to end the year with a forward order book approximately 15% higher than the $43m at the half year. New offices have been planned for Athens and Geneva and long term prospects for growth continue to be positive.

· Advisory fees from mandated business continued to grow in the Financial Division, Braemar Naves, although there were fewer material transaction based success fees in the period just ended than had been previously anticipated.

· The Logistics Division, Cory Brothers, traded in line with the previous year. A review of the strategic options available to maximise the value of this division is underway, which will include an evaluation of potential growth opportunities (both organic and by acquisition).

· The Engineering Division, Wavespec, saw continuing losses, with progress delays on the LNG storage technology and further delays with current projects tied to China due to ongoing trade negotiations between the US and China. The Board is therefore reassessing the carrying value of Wavespec's assets and will address all possible alternatives to improve its performance.

· The Group's associate, Aqualis Braemar, is making good progress in the integration of the Braemar Technical Services businesses. It has recently announced a return to Operating profits for the period since Braemar became a shareholder.

· Results for the year ended 29 February 2020 will be released in May 2020.

Outlook

· Shipping markets have seen significant falls in charter rates since the start of the calendar year, particularly in the larger sizes in the Tanker and Dry Bulk markets, due to reduced import volumes into China.

· Until the spread of COVID-19 shows signs of slowing, forecasts for economic growth and global trade are widely expected to continue to fall. Braemar expects this will have an effect on earnings for the first quarter of the year ending 28 February 2021 in the Shipbroking Division.

· The welfare of all Braemar staff and stakeholders is of paramount importance to the Group and therefore vigilance will be maintained to manage travel and any other activities that may heighten the risk to their wellbeing.

· The Company will continue to monitor the situation carefully and update the market as and when required. Whilst this uncertainty remains the Board, as previously announced, will keep the dividend under review.

 

Ron Series, Executive Chairman of Braemar commented: 'I am pleased with the Shipbroking performance last year but note that there is work to be done in improving the performance of the Logistics and Engineering Divisions. Whilst the current outlook is uncertain due to the Coronavirus impact, I believe that we are well positioned to benefit from a return to normal trading conditions.'

 

* Market expectations mean the current forecasts from finnCap

 

For further information, contact:

Braemar Shipping Services plc

Ron Series, Executive Chairman

Tel +44 (0) 20 3142 4100

Nick Stone, Finance Director

finnCap

Matt Goode/ James Thompson/ Kate Washington (Corporate Finance)

Andrew Burdis (ECM)

Tel +44 (0) 20 7220 0500

Buchanan

Charles Ryland / Victoria Hayns / Stephanie Watson / Matilda Abraham

Tel +44 (0) 20 7466 5000

 

Notes to Editors:

 

About Braemar Shipping Services plc

 

Braemar Shipping Services plc is a leading international provider of shipbroking, financial advisory, logistics and engineering services principally to the shipping and energy industries. Founded in 1972, Braemar employs approximately 530 people in 30 locations worldwide across its Shipbroking, Financial, Logistics and Engineering divisions.

 

Braemar joined the Official List of the London Stock Exchange in November 1997 and trades under the symbol BMS.

 

For more information, including our investor presentation, visit www.braemar.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTJTMBTMTIMTPM
Date   Source Headline
7th Jul 20257:00 amRNSTransaction in Own Shares
4th Jul 20252:47 pmRNSGrant of Share Incentives to PDMRs
4th Jul 20257:00 amRNSTransaction in Own Shares
3rd Jul 20257:00 amRNSTransaction in Own Shares
2nd Jul 20254:15 pmRNSDirector/PDMR Shareholding
2nd Jul 20254:07 pmRNSResults of 2025 Annual General Meeting
2nd Jul 20257:00 amRNSTransaction in Own Shares
1st Jul 20257:01 amRNSTotal Voting Rights
1st Jul 20257:00 amRNSTransaction in Own Shares
30th Jun 20257:00 amRNSTransaction in Own Shares
26th Jun 20257:00 amRNSTransaction in Own Shares
25th Jun 20257:00 amRNSTransaction in Own Shares
24th Jun 20257:00 amRNSTransaction in Own Shares
23rd Jun 20257:00 amRNSTransaction in Own Shares
20th Jun 20257:00 amRNSTransaction in Own Shares
19th Jun 20257:00 amRNSTransaction in Own Shares
18th Jun 20257:00 amRNSTransaction in Own Shares
17th Jun 20257:00 amRNSTransaction in Own Shares
13th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20257:00 amRNSTransaction in Own Shares
11th Jun 202511:11 amRNSInvestigation Update
11th Jun 20257:00 amRNSTransaction in Own Shares
10th Jun 20257:00 amRNSTransaction in Own Shares
9th Jun 20257:00 amRNSTransaction in Own Shares
6th Jun 20251:42 pmRNSNotice of 2025 Annual General Meeting
6th Jun 20257:00 amRNSTransaction in Own Shares
5th Jun 20257:00 amRNSTransaction in Own Shares
4th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSDirector/PDMR Shareholding
3rd Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 20254:50 pmRNSTotal Voting Rights
2nd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20257:00 amRNSTransaction in Own Shares
29th May 20257:01 amRNSCommencement of Share Buyback Programme
29th May 20257:00 amRNSFY25 Final Results
20th May 202510:00 amRNS-RInvestor Presentation at Mello London
15th May 20257:00 amRNSNotice of FY25 Results
2nd May 202512:14 pmRNSTotal Voting Rights
1st Apr 20253:43 pmRNSTotal Voting Rights
24th Mar 20257:00 amRNSFY25 Trading Update
7th Mar 20257:00 amRNSDirectorate Change
28th Feb 20259:04 amRNSTotal Voting Rights
31st Jan 20253:14 pmRNSTotal Voting Rights
31st Dec 20247:00 amRNSTotal Voting Rights
17th Dec 202410:23 amRNSHolding(s) in Company
10th Dec 20244:48 pmRNSHolding(s) in Company
10th Dec 20244:13 pmRNSDirector/PDMR Shareholding
3rd Dec 20249:27 amRNSTotal Voting Rights
28th Nov 20244:17 pmRNSPDMR Share Dealing
25th Nov 202411:41 amRNSPDMR Share Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.